Peer Review History
| Original SubmissionAugust 26, 2022 |
|---|
|
PONE-D-22-23909The selection of software and database for metagenomics sequence analysis impacts the outcome of microbial profiling and pathogen detectionPLOS ONE Dear Dr. Salvador, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see the detailed comments below for more information. Please submit your revised manuscript by Jan 20 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Brian B. Oakley, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. "PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: " ext-link-type="uri" xlink:type="simple">https://www.youtube.com/watch?v=_xcclfuvtxQ" 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The sequence analysis work was supported by the National Science Foundation under Grant No. DGE-1545433 to R.X. and startup funds to L.C.M.S. from the University of Georgia Office of Research. The sample collection, sequencing and analysis was done during S.R.’s tenure at the Ross University School of Veterinary Medicine, Saint Kitts and it was supported by internal grants from the Center for One Health and Tropical Medicine. We also would like to thank Dr. Kanae Shiokawa for her help with collection and processing of rat specimens." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf Additional Editor Comments (if provided): In light of the difficulty that has been experienced finding qualified reviewers for this manuscript and to avoid further delay, I am providing some comments in addition to those provided by Reviewer #1. As the points raised by the reviewer are addressed, please also address these additional issues. The first point follows a comment by Reviewer #1 regarding the use a control sample or one with some sort of an internal standard to help provide some absolute benchmarks in the comparison of these software tools. Since the results varied dramatically for multiple parameters, this begs the important question of which platform is best for whatever criteria may be of interest to users. In the Introduction section, some previous work is cited regarding synthetic datasets and so clearly some of this work has been done, but it is still an important requirement to have appropriate positive and negative controls in any dataset. This could be done in various ways - e.g. construction of an in silico dataset, qPCR of Leptospira from the biological samples used here, computational 'spiking in' of known quantities of Leptospira variant sequences, etc. Please address this important issue that will greatly help readers make meaningful choices as to the value of the software packages and databases compared. Second, some more care and strategic decisions should be made regarding the data presented. Many figures and tables (some as supplementary) are presented, but the points that are attempting to be made are not always clear. One minor example is in Table 1 where incomplete information is provided about the computational resources required. This information does not always make sense - for example, how were 0 Mb of 'resources' used for Bracken? Finally, one additional analysis that might be interesting would be a beta-diversity analysis such as a PCoA of results obtained, testing for significant clustering according to approach (e.g. alignment vs k-mer based). As noted in the manuscript, the increasing use of metagenomics makes a manuscript such as this potentially very useful to the field. I feel the changes above should significantly strengthen the work. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript addresses a relevant piece of information on several metagenomics profiling tools' performance and outcome discrepancies. Its content is undoubtedly attractive to researchers in the field, raising awareness and caution on software selection and results interpretation. It is both technically and scientifically sound, however lacks expatiating on important technical features of a full metagenomics workflow, which I better explain through the comments below. 1. Even clearly understanding that taxonomic profiling and taxa abundance statistical analyses were the most important aspects of the software comparison's scope of this manuscript, I feel like it lacks information on assembly steps (assembly, binning, bins' reassembly) of WGS metagenomics, as well as ESVs clustering for 16S-NGS. I encourage authors to open a paragraph on either Methods (if they have used any metagenomics assembler for the preparation of this manuscript) or Results section expatiating on the importance of both assembly/binning (metagenomics) and ESV generation (16S) steps within a metagenomics/microbiomics pipeline. 2. Was there any "true" dataset used to rely on for Precision calculations on Fig.3? This must be briefly explained it in Fig.3 caption. Who are the true positive taxa and where do they come from? 3. line 366: Replace "prevision" by "precision". 4. line 449: Although aware that BC acronym was first introduced on the Methods section, I'd rather have it written out again on the first time it appears in the Results. So, Bray-Curtis (BC) on line 449, as well. Many readers may ignore Methods section if they're not planning to do a similar work. 5. Fig 7a is an "UpSet Venn Diagram". Please introduce it as such on its caption. 6. Considering what is displayed in Fig 7b (summed to my #1 comment in this review), it came to my attention that a different, and potentially better, outcome might have been achieved if each sample had their own generated bins or MAGs (metagenome-assembled genomes) to be compared against each other through a pseudoalignment approach (e.g. raw reads in sample_A pseudoaligned against MAGs from sample_B and raw reads in sample_B pseudoaligned against MAGs from sample_A). Authors must consider expatiating on that as well for this particular result interpretation. 7. Ok, just saw lines 675-677 from Discussion where assembly and binning strategies were finally mentioned (although quite briefly). It doesn't exclude the need of addressing my comments #1 and #6 above, which will reinforce what is currently briefly mentioned. 8. line 680: Replace "is" by "are". 9. Please make sure figures will have a better resolution for publication. 10. Raw sequencing data must be deposited in a public repository (e.g. SRA from NCBI), and SRR accession numbers provided in the manuscript (or a NCBI BioProject ID that will point to the SRRs). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The selection of software and database for metagenomics sequence analysis impacts the outcome of microbial profiling and pathogen detection PONE-D-22-23909R1 Dear Dr. Salvador, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Brian B. Oakley, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for the revisions and responses to the previous comments. After careful review, all of the points that were raised have been adequately addressed and the manuscript has been substantially improved. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-23909R1 The selection of software and database for metagenomics sequence analysis impacts the outcome of microbial profiling and pathogen detection Dear Dr. Salvador: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Brian B. Oakley Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .